Bimatoprost

Generic name
Bimatoprost
Brand name
ATC Code
S01EE03
Compare …

Bimatoprost

Dosages
Side effects in children
Warnings & precautions in children
Contra-indications in children

Interactions
PK
Renal impairment
References

Pharmacokinetics in children

No studies have been carried out into the pharmacokinetic parameters of bimatoprost in children

dose recommendation of formulary compared to licensed use (on-label versus off-label)

No information is present at this moment.

Available formulations

No information is present at this moment.

Dosages

Glaucoma
  • Ocular
    • 1 month up to 18 years
      • in the affected eye 1 drop(s)/day in 1 dose In the evening.

      • No studies have been carried out into the use of bimatoprost in children

    • Term neonate
      • in the affected eye 1 drop(s)/day in 1 dose In the evening.

      • No studies have been carried out into the use of bimatoprost in children

Renal impaiment in children > 3 months

No information available on dose adjustment in renal impairment.

The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here

Side effects

No information is present at this moment.

The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here

Contra-indications

No information available on specific contra indications in children.

The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here

Warnings & precautions

No information available on specific warnings and precautions in children.

Interactions

The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here

ANTIGLAUCOMA PREPARATIONS AND MIOTICS

This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.

Parasympathomimetics
S01EB01
Carbonic anhydrase inhibitors
S01EC01
S01EC03
Beta blocking agents
S01ED01
Prostaglandin analogues
S01EE01
S01EE04
Other antiglaucoma preparations
S01EX
OTHER ANTIGLAUCOMA PREPARATIONS
S01EX

Reference

  1. SPC Lumigan (Allergan Pharmaceuticals Ireland) 20/02/2007, EU/1/02/205/001-002

Changes

Therapeutic Drug Monitoring


Overdose